Merck and BGI Initiate “Substantive” Relationship
September 15, 2010 at 18:46 PM EDT
Merck has signed a letter of intent with BGI (formerly the Beijing Genomics Institute) that will “initiate and develop a working relationship,” according to the press release. However, citing anonymous sources, Bio-IT World says this innocuous wording greatly understates the depth of the collaboration, which it calls “substantive, wide-ranging and long-term.” More details.... Stock Symbol: (NYSE: MRK)